HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

A recent appellate decision that allowed West Virginia to block access to the abortion-inducing drug mifepristone is fueling ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

But the West Virginia abortion-pills case, GenBioPro v. Raynes, drew 10 friend-of-the-court briefs supporting the abortion-pills maker and 47 friend-of-the-court briefs supporting the state of West ...

Emergency room visits after abortion-drug use were 79 percent more likely to be miscoded as natural miscarriages compared with those following surgical abortions, according to a new study ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

Food and Drug Administration Commissioner Martin Makary confirmed in a Monday letter to the Missouri senator that the agency will conduct a safety review of the abortion pill mifepristone. Makary’s ...

Food and Drug Administration (FDA) head Marty Makary vowed to review the abortion drug mifepristone after previously saying he had no plans to take action on the drug.

Republican Sen. Josh Hawley’s quest to legitimize a junk science report undermining the safety of a widely used abortion pill was fully realized this week. “As with all drugs, FDA continues to ...